Skip Nav Destination
Dendritic cell vaccination as postremission treatment to prevent or delay relapse in acute myeloid leukemia
Genetic risk stratification to reduce inhibitor development in the early treatment of hemophilia A: a SIPPET analysis
Ruxolitinib for essential thrombocythemia refractory to or intolerant of hydroxyurea: long-term phase 2 study results
Long-term results of a phase 2 study of rituximab and bendamustine for mucosa-associated lymphoid tissue lymphoma
Issue Archive
October 12 2017
Table of Contents
INSIDE BLOOD COMMENTARIES
BLOOD SPOTLIGHT
REVIEW ARTICLE
CLINICAL TRIALS AND OBSERVATIONS
IMMUNOBIOLOGY AND IMMUNOTHERAPY
Dendritic cell vaccination as postremission treatment to prevent or delay relapse in acute myeloid leukemia
Clinical Trials & Observations
Sébastien Anguille,Ann L. Van de Velde,Evelien L. Smits,Viggo F. Van Tendeloo,Gunnar Juliusson,Nathalie Cools,Griet Nijs,Barbara Stein,Eva Lion,Ann Van Driessche,Irma Vandenbosch,Anke Verlinden,Alain P. Gadisseur,Wilfried A. Schroyens,Ludo Muylle,Katrien Vermeulen,Marie-Berthe Maes,Kathleen Deiteren,Ronald Malfait,Emma Gostick,Martin Lammens,Marie M. Couttenye,Philippe Jorens,Herman Goossens,David A. Price,Kristin Ladell,Yoshihiro Oka,Fumihiro Fujiki,Yusuke Oji,Haruo Sugiyama,Zwi N. Berneman
LYMPHOID NEOPLASIA
PHAGOCYTES, GRANULOCYTES, AND MYELOPOIESIS
PLATELETS AND THROMBOPOIESIS
THROMBOSIS AND HEMOSTASIS
Genetic risk stratification to reduce inhibitor development in the early treatment of hemophilia A: a SIPPET analysis
Clinical Trials & Observations
Brief Report
Frits R. Rosendaal,for the SIPPET Study Group,Roberta Palla,for the SIPPET Study Group,Isabella Garagiola,for the SIPPET Study Group,Pier M. Mannucci,for the SIPPET Study Group,Flora Peyvandi,for the SIPPET Study Group
TRANSPLANTATION
LETTERS TO BLOOD
Ruxolitinib for essential thrombocythemia refractory to or intolerant of hydroxyurea: long-term phase 2 study results
Clinical Trials & Observations
Srdan Verstovsek,Francesco Passamonti,Alessandro Rambaldi,Giovanni Barosi,Elisa Rumi,Elisabetta Gattoni,Lisa Pieri,Huiling Zhen,Muriel Granier,Albert Assad,Mario Cazzola,Hagop M. Kantarjian,Tiziano Barbui,Alessandro M. Vannucchi
Long-term results of a phase 2 study of rituximab and bendamustine for mucosa-associated lymphoid tissue lymphoma
Clinical Trials & Observations
Antonio Salar,Eva Domingo-Domenech,Carlos Panizo,Concepción Nicolás,Joan Bargay,Ana Muntañola,Miguel Canales,José Luis Bello,Juan Manuel Sancho,José Francisco Tomás,María José Rodríguez,Javier Peñalver,Carlos Grande,José Javier Sánchez-Blanco,Luis Palomera,Reyes Arranz,Eulogio Conde,Mar García,Juan Fernando García,Dolores Caballero,Carlos Montalbán
BLOOD WORK
-
Cover Image
Cover Image
![issue cover]()
A 10 μm-thick spleen cryosection of a twinfilin 2a−/− mouse was stained for endothelial (anti–CD105-A647; magenta) and platelet (anti–GPIb-A488; cyan) markers and analyzed by confocal microscopy. See the article by Stritt et al on page 1746.
- PDF Icon PDF LinkFront Matter
- PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkBack Matter
- PDF Icon PDF LinkEditorial Board
Advertisement intended for health care professionals
Email alerts
Advertisement intended for health care professionals
